Ivory (Healthcare Technology Systems) key facts
as of Oct 2026- Developer of a brain health screening system designed to understand brain health.
- Ivory (Healthcare Technology Systems) is valued at approximately $4.9M as of Oct 2026 (last reported valuation).
- It has raised $2.5M; the latest was Later Stage VC ($1.0M) in Apr 2026.
- Notable investors include Draper Associates, Capital A Partners (Netherlands), Rajeev Singh, 1Crowd, AL Trust (India) — 16 tracked in total.
- Status: Privately Held (backing).
Ivory (Healthcare Technology Systems)'s last reported valuation, Apr 2025. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch Ivory (Healthcare Technology Systems): the Monday email on marks, rounds and moves
Ivory (Healthcare Technology Systems) funding rounds
No funding rounds for Ivory (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Ivory (Healthcare Technology Systems)
16+Ivory (Healthcare Technology Systems) valuation
Ivory (Healthcare Technology Systems)'s last reported valuation was $4.9 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.
Ivory (Healthcare Technology Systems) investors
16 investors are on record for Ivory (Healthcare Technology Systems), including Draper Associates, Capital A Partners (Netherlands), Rajeev Singh and 1Crowd.
About Ivory (Healthcare Technology Systems)
Developer of a brain health screening system designed to understand brain health. The company detects neurodegenerative risks early and offers personalized brain health services through neuroscience-backed assessments and interactive games, enabling the elderly to help fight dementia.
- Sector
- Healthcare
- HQ
- Delhi, India
- Founded
- 2021
- Employees
- 5
- Website
- liveivory.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.